We support university researchers with reliable antibody production tailored to grant budgets and publication timelines. From pilot studies to final publications, evitria delivers the reproducibility and quality that peer-reviewed research requires.
We provide a bespoke partnership tailored to your specific laboratory goals and experimental requirements.
From initial High Throughput screening to the high fidelity expression of promising candidates, we deliver the molecular consistency needed for reproducible results and high impact publications.
Academic success depends on the ability to replicate findings across multiple years and different researchers. Our platform ensures that your experimental foundation remains stable from the first pilot study to the final thesis or publication.
Exact Reproductions: We can replicate the exact antibody you need from a previous run with perfect consistency.
Reduced Risk: Our stable processes ensure that your top candidates perform exactly as expected during follow up studies.
Flexible Scaling: Start with 0.1 mg for initial validation and scale up seamlessly as your research program progresses.
We leverage fifteen years of exclusive expertise to help your laboratory express complex formats and challenging constructs that often fail in standard systems.
Publication Timelines
Our four-week standard delivery timeline provides the speed and reliability needed to meet aggressive publication deadlines and stay ahead of the competition.
Grant Funding Realities
We provide transparent pricing and itemized quotations to ensure that your antibody production remains defensible and aligned with your specific grant allocations.
The Reproducibility Crisis
We eliminate host cell variability by using an industry-standard CHO platform that ensures your data remains a reliable foundation for future grant renewals.
What our customers say
Long-lasting, healthy customer relationships are very
important to us. Anonymity is therefore part of our corporate DNA.
“We have been working with evitria for several years and highly appreciate the high consistency of the delivered material.”
Sr. Scientist, Biotherapeutics, Switzerland
“We have been working with evitria since 2022. We appreciate the openness and flexibility of the team, the high speed and quality of the proteins they deliver.”
Radiopharm Theranostics Ltd.
“We are happy paying for the assured quality that evitria brings.”
Sr Scientist, Biotherapeutics, Series B Startup, Boston
140,000+
transfections performed
25,000 +
Antibodies expressed
15+ years
dedicated exclusively to recombinant antibody expression
Global reach
serving clients across Americas, Europe, Asia, and Australia
Ready to Support Your Research with Reliable Antibodies?
Whether you are planning experiments for a new grant or need additional material for ongoing research our team is ready to help you optimize your antibody design.
Request Academic Pricing & Consultation!
A Proven Track Record in Global Academia
Our commitment to quality has established evitria as a trusted partner for university laboratories and research institutes worldwide.
We provide the specialized expertise necessary to support the journey from initial hypothesis to high impact publication.
FAQs about Antibody Production for Academic Research
We regularly support researchers by providing detailed technical specifications and production strategies for inclusion in grant submissions. This documentation helps strengthen your research proposal and demonstrates to reviewers that your preliminary data is generated using industry standard host systems.
We have extensive experience working with university purchasing departments and understand the need for multiple vendor quotes. Our team provides responsive service and transparent pricing to ensure that administrative requirements do not delay the start of your research.
We maintain exhaustive digital records of every transfection performed in our facility to ensure exact reproducibility. This allows your laboratory to maintain continuity when a project is handed off to a new researcher or when additional material is needed for follow up studies.
Every project includes a comprehensive analytics package suitable for publication in peer reviewed journals. This includes data for purity and concentration as well as SEC and SDS-PAGE results to provide the validation that reviewers and editors expect from high impact research.
Many academic projects involve novel formats such as bispecifics or fragments that often fail in standard laboratory systems. We leverage fifteen years of exclusive expertise to help your lab express these challenging constructs, providing the technical troubleshooting needed to turn complex designs into publishable results.
We recognize the importance of academic research in driving scientific innovation and offer competitive pricing structures tailored to the realities of university funding. Contact our team to discuss your specific project and we will work with you to provide a solution that balances high quality data with your budgetary constraints.
Yes, we regularly provide detailed and itemized quotations that can be directly integrated into grant applications or institutional budget planning. Our team understands that academic funding requires clear and defensible cost breakdowns to satisfy internal and external financial oversight.
Our standard timeline for recombinant antibody expression and purification is four weeks, while our High Throughput (HTP) service for smaller scales can be completed in as little as three weeks. This reliable schedule allows you to plan your experiments with precision and meet critical project milestones or thesis deadlines.
We understand the competitive nature of academic publishing and the pressure of “revised version” deadlines. Because our project initiation begins within 24 hours at our Zurich facility, we eliminate administrative delays and provide the fastest possible path from sequence to purified antibody to help you meet aggressive timelines.
Our team acts as your Scientific Co-Pilot by providing bespoke guidance during the design phase. We can offer insights on sequence optimization or suggest specific engineering options, such as GlymaxX® for afucosylation or mAbsolve for Fc-silencing, to ensure your construct is optimized for your specific research goals.
evitria AG – Supporting academic researchers worldwide with reliable antibody production that enables publishable results within grant constraints. Premium Swiss based specialist for recombinant antibody expression. All products are for research and preclinical use only.
Let’s get in touch with our experts now!
Our team of experts looks forward to
answering all your concerns regarding our services and solutions.
We Value Your Privacy
This website uses cookies to enhance your browsing experience and provide personalized services. We require your consent to set these cookies on your device.
Your Privacy
This site uses tracking technologies. You may opt in or opt out of the use of these technologies.
Marketing cookies and services are used to deliver personalized advertisements, promotions, and offers. These technologies enable targeted advertising and marketing campaigns by collecting information about users' interests, preferences, and online activities.
Analytics cookies and services are used for collecting statistical information about how visitors interact with website. These technologies provide insights into website usage, visitor behavior, and site performance to understand and improve the site and enhance user experience.
Personalization cookies enable the website to remember your choices and provide enhanced, more personal features. These cookies may track your preferences and show you relevant content based on your browsing patterns.
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedback, and other third-party features.
Essential cookies are necessary for the website to function properly. These cookies ensure basic functionalities and security features of the website.